Provera

DRUG3 trials

Sponsors

Kaiser Permanente, National Institute of Mental Health (NIMH), University of British Columbia

Conditions

Endometrium CancerMenorrhagiaPerimenopause-Related DepressionUterine Hemorrhage

Phase 2

Estrogen Receptor Beta and Mood

CompletedNCT03689543

National Institute of Mental Health (NIMH)Perimenopause-Related Depression

Start: 2019-05-23End: 2024-09-09Updated: 2025-09-16

Phase 4

Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer

CompletedNCT05651282

University of British ColumbiaEndometrium Cancer

Start: 2023-03-15End: 2025-11-30Updated: 2026-04-13

Unknown Phase

Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial

CompletedNCT00350480

Kaiser PermanenteMenorrhagia, Uterine Hemorrhage

Start: 2003-04-30End: 2005-06-30Target: 240Updated: 2015-03-11

Related Papers

Data from The Progesterone Challenge Test as a Functional Biomarker of Endometrial Cancer Risk: Results from a Prospective Feasibility Study

2026-04-01

The Progesterone Challenge Test as a Functional Biomarker of Endometrial Cancer Risk: Results from a Prospective Feasibility Study

Cancer Prevention Research2026-02-03

Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial.

2006-10-0159 citations